Remdesivir
A broad-spectrum antiviral prodrug with potent in vitro antiviral activity against a diverse panel of RNA viruses such as Ebola virus, MERS-CoV and SARS-CoV. It is currently in Phase III clinical trials for the treatment of Covid-19 in adults. It has a role as an antiviral drug, a prodrug and an anticoronaviral agent. It is a carboxylic ester, a pyrrolotriazine, a nitrile, a phosphoramidate ester, a C-nucleoside and an aromatic amine. It is functionally related to a GS-441524.
| Catalog Number | API1809249373 |
| Alternative Name(s) | 3QKI37EEHE GS 5734 GS 5734 [WHO-DD] GS-5734 |
| Research Area | Antivirus APIs |
| Molecular Formula | C27H35N6O8P |
| CAS# | 1809249-37-3 |
| SMILES | CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4 |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/remdesivir-item-11362.html |